From Raw Data to Reliable Results. In Clicks, Not Code
Validated nf-core pipelines from raw sequencing data to reproducible insights. Automated for reliability, with Notebooks for deeper exploration.
End-to-End
Bioinformatics Variant Analysis Cohort Discovery Genomic Intelligence
Meet BioMind, our next-level BioAgents layer Pan.bio is the AI-powered, end-to-end genomics platform connecting bioinformatics workflows, variant interpretation, and patient cohort data, all in one place. Built privacy-first with in-country deployment and HIPAA, GDPR, SOC 2, and ISO 27001 compliance baked into the architecture.
Trusted by scientists and researchers from
Platform
One Platform.
Every Step of
Genomic Analysis.
From raw sequencing data to clinical reports to cohort discovery, Pan.bio brings the entire genomic workflow into a single AI-powered platform; so teams stop stitching tools together and start delivering results.
Explore. Experiment. Standardize.
A pre-configured notebook environment where BioMind generates code, debugs errors, and helps turn one-off discoveries into reusable team workflows.
Variant Interpretation & Classification
Guideline-aware clinical variant classification powered by ACMG/AMP, CanVIG, ACGS, and ClinGen. AI-assisted, human-controlled.
A Marketplace for Real-World Patient Data
Connecting hospitals and labs with pharma and biotech researchers. Unlock underrepresented populations while keeping data under provider ownership at every step.
Solutions
Built for how you work
Five teams. One platform. Tailored to each.
FASTQ
Align
Analyze
Results
Research Labs & Academia
Run Reproducible Genomic Analysis Without Writing Code
Validated pipelines, AI-assisted notebooks, and shared workflows your whole team can standardize on.
Learn More
BRCA2Chr 13q13.1
c.5946del
PVS1PM2PP3
87
PATHOGENIC Clinical Diagnostic Labs
Turn Variant Interpretation from Hours into Minutes
Guideline-aware classification grounded in ACMG/AMP, CanVIG, ACGS, and ClinGen with AI assistance for the hard cases.
Learn More
MENA
S. Asia
EUR
E. Africa
Cohort
Pharma & Biotech R&D
Access Real-World Cohorts You Can't Find Anywhere Else
Population-specific patient data from MENA and South Asia, assembled in weeks, not months.
Learn More
Monthly Data Revenue
$0M
+34% YoY
Hospitals & Healthcare
Turn Existing Genomic Data into a Revenue Stream
Monetize de-identified clinical data without losing ownership, jurisdiction, or compliance.
Learn More
Genomics Lab
Live
Clinical Core
Live
Research Unit
Live
Bioinformatics Service Providers
Standardize Service Delivery Across Every Client
Reproducible pipelines, multi-tenant isolation, and a unified AI layer to scale your operations.
Learn More
Our Reach
A growing global community
Trusted by scientists from leading research labs, hospitals, and clinical institutions worldwide.
Why Pan.bio
Built for advanced genomics
Everything an advanced genomics operation needs, privacy, access, and intelligence, in one platform.
Data Sovereignty & Privacy
Deploy on your country’s compliant cloud or on-premise. Data never leaves your jurisdiction.
Built for Underrepresented Populations
Population-specific cohorts and references for MENA and South Asia, populations missing from every major public database.
No-Code Accessibility
Run validated pipelines through a clean interface, or describe what you need to BioMind in plain English.
End-to-End Coverage
Sequencing → pipelines → variant interpretation → clinical reports → cohort discovery, all in one platform.
One AI, Every Application
BioMind is a unified AI copilot that adapts to every product, not three separate bots bolted on.
Compliance as Architecture
HIPAA, GDPR, SOC 2 Type 2, and ISO 27001 enforced at the infrastructure level, not as documentation your team manages.
About Pan.bio
Built to translate the
language of life
Pan.bio exists to empower scientists to transform genomic data into scientific breakthroughs. We build the AI-powered, end-to-end platform that bridges the distance between raw sequences and world-changing insights, making genomic research faster, more accurate, and accessible to teams who've been left out of the global research conversation for too long.
Our focus on underrepresented populations isn't a marketing line, it's the reason we exist. From MENA breast cancer research to Pan-Arab diabetes cohorts, we're building the infrastructure that lets clinicians, researchers, and pharma teams generate the genomic insights their populations have been missing from for decades.
"We're not just building software, we're building equity in genomics."
HIPAA PHI safeguards
GDPR EU data privacy
SOC 2 Trust services criteria
ISO Infosec management
Enforced at the infrastructure level, your data stays in your jurisdiction, always.
0
researchers trust Pan.bio to power their genomic discovery
No credit card required · Start in minutes